))
Better Health, Brighter Future for Rare with Dan Curran
Manage episode 378782010 series 3349924
Contenido proporcionado por n-Lorem Foundation and N-Lorem Foundation. Todo el contenido del podcast, incluidos episodios, gráficos y descripciones de podcast, lo carga y proporciona directamente n-Lorem Foundation and N-Lorem Foundation o su socio de plataforma de podcast. Si cree que alguien está utilizando su trabajo protegido por derechos de autor sin su permiso, puede seguir el proceso descrito aquí https://es.player.fm/legal.
Dr. Daniel Curran leads Takeda’s efforts to unlock innovation and deliver transformative medicines in a variety of rare-disease areas. Dan embraces learning from, collaborating with, and meeting members of the rare disease community in an effort to produce treatments that result in better health and a brighter future for rare.
- 2:02 How rare disease is defined at Takeda
- 4:10 Rare disease units at Takeda
- 5:23 How Takeda economically justifies half of their pipeline being rare disease drugs
- 9:06 The price of rare disease drugs is too high
- 12:15 Why rare disease efforts are often associated with hematology
- 14:57 What Dr. Curran enjoys about leading Takeda's rare genetics and hematology therapeutic unit
- 16:42 Dr. Curran's professional journey
- 20:50 Takeda's choice to support n-Lorem
52 episodios
Compartir
